These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38545422)

  • 21. Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing.
    Jamdar F; Farzaneh F; Navidpour F; Younesi S; Balvayeh P; Hosseini M; Ghodssi-Ghasemabadi R
    Infect Agent Cancer; 2018; 13():6. PubMed ID: 29416557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
    Carozzi F; De Marco L; Gillio-Tos A; Del Mistro A; Girlando S; Baboci L; Trevisan M; Burroni E; Grasso S; Giorgi Rossi P; Ronco G;
    J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and genotype screening of human papillomavirus among women attending a private hospital in Northern Cyprus: an 11-year retrospective study.
    Baddal B; Oktay MN; Bostanci A; Yenen MC
    BMC Womens Health; 2023 Jun; 23(1):297. PubMed ID: 37270608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guidelines for application of molecular tests identyfying HR HPV DNA in the prevention of cervical cancer. Statement of experts from PGS (PTG) and NCLD (KIDL)].
    ;
    Ginekol Pol; 2013 May; 84(5):395-9. PubMed ID: 23819408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection.
    Chen Z; Lin H; Zheng J; Cai L; Chen Z; Li J; Yu L
    BMC Infect Dis; 2022 Nov; 22(1):893. PubMed ID: 36443703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
    Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
    Checchi M; Mesher D; Panwar K; Anderson A; Beddows S; Soldan K
    Vaccine; 2023 Oct; 41(45):6734-6744. PubMed ID: 37821315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
    PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
    Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
    Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability and Feasibility of Human Papillomavirus Vaccine Introduction in Cameroon: A Mixed-Methods Study.
    Guenou E; Wakam Nkontchou B; Vouking Zambou M; Buh Nkum C; Mfoulou Minso AC; Napa YL; Beyala Bita'a L; Murhabazi Bashombwa A; Tchio-Nighie KH; Ateudjieu J; d'Alessandro E
    Cureus; 2024 May; 16(5):e60723. PubMed ID: 38903277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of human papillomavirus infection in women in Portugal: the CLEOPATRE Portugal study.
    Pista A; de Oliveira CF; Cunha MJ; Paixao MT; Real O;
    Int J Gynecol Cancer; 2011 Aug; 21(6):1150-8. PubMed ID: 21792018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
    BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.
    Meloni A; Pilia R; Campagna M; Usai A; Masia G; Caredda V; Coppola RC
    J Public Health Res; 2014 Mar; 3(1):157. PubMed ID: 25170506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
    Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
    BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K
    Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.